Cargando…
Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells
BACKGROUND: A recent study reported that mesenchymal stem cells possess potential cellular therapeutic properties for treating patients with chronic obstructive pulmonary disease, which is characterized by emphysema. We examined the potential therapeutic effect of Wharton's Jelly-derived mesenc...
Autores principales: | Park, Jin-Soo, Kim, Hyun Kuk, Kang, Eun-Young, Cho, RyeonJin, Oh, Yeon-Mok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435932/ https://www.ncbi.nlm.nih.gov/pubmed/30302955 http://dx.doi.org/10.4046/trd.2018.0044 |
Ejemplares similares
-
Effects of Wharton's jelly-derived mesenchymal stem cells on chronic obstructive pulmonary disease
por: Cho, Jun Woo, et al.
Publicado: (2019) -
Effect of Slit/Robo signaling on regeneration in lung emphysema
por: Park, Jin-Soo, et al.
Publicado: (2021) -
Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021) -
The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021) -
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
por: Saleh, Mahshid, et al.
Publicado: (2022)